DBVT FY 2013 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$494M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$251,318+9.0% YoY

Gross Profit

$110,46944.0% margin

Operating Income

-$27M-10932.8% margin

Net Income

-$27M-10579.0% margin

EPS (Diluted)

$-13.00

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$26M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$85M

Total Liabilities

$11M

Stockholders' Equity

$74M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$251,318	$230,592	+9.0%
Gross Profit	$110,469	$120,879	-8.6%
Operating Income	-$27M	-$18M	-55.5%
Net Income	-$27M	-$17M	-56.2%